Inspira Secures $580,000 Order from NYU Langone
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 18 2026
0mins
Source: Newsfilter
- Significant Order Value: Inspira Technologies has secured a $580,000 commercial purchase order from NYU Langone Hospital, marking a successful application of the ART100 extracorporeal blood circulation system and is expected to enhance the company's competitiveness in the medical device market.
- Successful Clinical Evaluation: The order follows the completion of a multi-patient clinical evaluation where ART100 systems were utilized in the treatment of over 30 patients across cardiopulmonary and surgical cases, directly influencing the hospital's decision to transition from clinical assessment to commercial procurement.
- Strategic Importance: This order not only provides Inspira with a crucial hospital reference but also lays the groundwork for ongoing commercial discussions with additional U.S. and international hospital systems, demonstrating the operational value of the ART100 platform in real hospital use.
- Future Development Potential: The Director of Extracorporeal Technology at NYU Langone noted that the ART100 showcased flexibility and economic potential, indicating a promising direction for the future of extracorporeal support technologies, which could open up more market opportunities for Inspira.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IINN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IINN
About IINN
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
QTREX Quantum Secures $10 Million in Private Placement Financing
- Financing Agreement: QTREX Quantum Ltd. has signed a securities purchase agreement with a new investor to issue 6,666,667 ordinary shares at $1.50 per share, expecting gross proceeds of approximately $10 million, which will be utilized for working capital and general corporate purposes, thereby enhancing the company's competitive edge in quantum hardware infrastructure.
- Accelerating Strategic Transformation: CEO Dagi Ben-Noon stated that this financing will accelerate the company's transformation into a quantum hardware infrastructure firm, particularly in commercializing its AME-based cryogenic interconnect platform, while enhancing R&D capabilities to support critical hardware applications.
- Registration Statement Commitment: Under a registration rights agreement with the investor, QTREX has committed to filing a registration statement with the SEC covering the resale of the ordinary shares and pre-funded warrants sold in the offering, ensuring future liquidity and market access.
- Market Outlook: QTREX is focused on developing high-density, thermally optimized quantum connectivity solutions, and in addition to quantum technology, the company is actively advancing its medical technology portfolio, indicating significant growth potential across multiple critical markets.
See More
Inspira Secures $580,000 Order from NYU Langone
- Significant Order Value: Inspira Technologies has secured a $580,000 commercial purchase order from NYU Langone Hospital, marking a successful application of the ART100 extracorporeal blood circulation system and is expected to enhance the company's competitiveness in the medical device market.
- Successful Clinical Evaluation: The order follows the completion of a multi-patient clinical evaluation where ART100 systems were utilized in the treatment of over 30 patients across cardiopulmonary and surgical cases, directly influencing the hospital's decision to transition from clinical assessment to commercial procurement.
- Strategic Importance: This order not only provides Inspira with a crucial hospital reference but also lays the groundwork for ongoing commercial discussions with additional U.S. and international hospital systems, demonstrating the operational value of the ART100 platform in real hospital use.
- Future Development Potential: The Director of Extracorporeal Technology at NYU Langone noted that the ART100 showcased flexibility and economic potential, indicating a promising direction for the future of extracorporeal support technologies, which could open up more market opportunities for Inspira.
See More
Inspira Technologies Reshapes Strategy with Quantum Connectivity Focus
- Strategic Restructuring: Inspira Technologies aims to become a foundational connectivity layer for the quantum computing industry through the acquisition of the AME platform, with market projections reaching $72 billion by 2035, highlighting the company's strategic importance in a rapidly growing tech sector.
- Accelerated Commercial Activity: Within weeks of the acquisition, Inspira deployed an AME system at a U.S. defense customer and generated over $1 million in revenue from recent transactions, demonstrating strong demand and market potential for its platform.
- Medical Business Optimization: The company is actively working to sell parts of its medical business to reduce costs and unlock strategic value, with expectations to finalize a transaction by Q3 2026, potentially providing significant non-dilutive capital to strengthen the balance sheet.
- Quantum Connectivity Collaboration: A joint development agreement with Qarakal Quantum Ltd. will advance the validation of Inspira's quantum connectivity architecture, expected to further enhance the company's market position within the quantum ecosystem.
See More
Inspira Secures $596,000 Order for AME System
- Significant Order Value: Inspira Technologies has secured a $596,000 purchase order from a leading Irish technological research university, with 40% of the upfront payment already received, which not only provides immediate cash flow but also lays the groundwork for future recurring revenue.
- Technology Fit: The order involves an Additively Manufactured Electronics (AME) system capable of fabricating complex three-dimensional structures with micron-level precision, directly addressing the customer's needs in information and communications technology and quantum networking research, showcasing Inspira's competitiveness in the high-tech market.
- Recurring Revenue Stream: Beyond the system price, the order establishes a recurring revenue stream from proprietary consumables, wear parts, and fixed annual service fees, enhancing the company's financial stability and long-term profitability through this structured revenue model.
- Market Expansion Potential: Inspira plans to deliver and deploy the system in the coming weeks, accompanied by tailored advanced application training for the university's research teams, with expectations that this will serve as a reference installation to foster engagement with additional academic and commercial institutions across Europe and beyond.
See More
Inspira Successfully Delivers AME System to Tier-1 U.S. Defense Customer
- Successful System Delivery: Inspira Technologies has successfully delivered its Additively Manufactured Electronics (AME) system to a Tier-1 U.S. defense customer, marking a significant enhancement in the company's commercial execution in the defense sector, which is expected to drive future financial growth.
- Strategic Partnership Opportunity: This delivery not only meets the customer's needs in advanced technologies such as quantum computing and superconducting systems but also establishes a recurring revenue stream for Inspira, ensuring long-term profitability beyond the initial system sale.
- Technological Advantage Realized: Inspira's AME platform is specifically designed to overcome hardware bottlenecks related to complex component integration and extreme miniaturization, enabling rapid fabrication of highly integrated electronic structures, thereby enhancing its application capabilities in high-density and thermally optimized operations.
- Market Demand Confirmation: CEO Dagi Ben-Noon stated that this deployment confirms the commercial demand for the AME platform in top-tier defense operations, potentially serving as a powerful catalyst for the company's accelerating financial momentum and growth.
See More
Inspira Technologies Advances in Quantum Computing with Major Client Engagement
- Technology Implementation Launch: Inspira Technologies has announced the commencement of AME technology implementation with one of the world's top ten U.S. companies, marking a significant step in its strategic expansion into advanced technology markets, which is expected to enhance the company's market share in quantum computing.
- Client Validation of Platform: The client operates at the forefront of artificial intelligence and computing infrastructure, and the application of Inspira's AME platform at their R&D facility will provide high-level validation of the technology's practical effectiveness, enhancing market confidence in the company.
- Revenue Generation Potential: This collaboration not only strengthens the ongoing commercial relationship with the client but also indicates a rising demand for next-generation hardware connectivity solutions, potentially generating a stable revenue stream for the company.
- Strategic Opportunity Expansion: Inspira believes that the client's participation will support additional strategic opportunities, further solidifying its AME platform's position in advanced technology markets and driving the company's future growth potential.
See More
QTREX Quantum Secures $10 Million in Private Placement Financing
- Financing Agreement: QTREX Quantum Ltd. has signed a securities purchase agreement with a new investor to issue 6,666,667 ordinary shares at $1.50 per share, expecting gross proceeds of approximately $10 million, which will be utilized for working capital and general corporate purposes, thereby enhancing the company's competitive edge in quantum hardware infrastructure.
- Accelerating Strategic Transformation: CEO Dagi Ben-Noon stated that this financing will accelerate the company's transformation into a quantum hardware infrastructure firm, particularly in commercializing its AME-based cryogenic interconnect platform, while enhancing R&D capabilities to support critical hardware applications.
- Registration Statement Commitment: Under a registration rights agreement with the investor, QTREX has committed to filing a registration statement with the SEC covering the resale of the ordinary shares and pre-funded warrants sold in the offering, ensuring future liquidity and market access.
- Market Outlook: QTREX is focused on developing high-density, thermally optimized quantum connectivity solutions, and in addition to quantum technology, the company is actively advancing its medical technology portfolio, indicating significant growth potential across multiple critical markets.
See More
Inspira Secures $580,000 Order from NYU Langone
- Significant Order Value: Inspira Technologies has secured a $580,000 commercial purchase order from NYU Langone Hospital, marking a successful application of the ART100 extracorporeal blood circulation system and is expected to enhance the company's competitiveness in the medical device market.
- Successful Clinical Evaluation: The order follows the completion of a multi-patient clinical evaluation where ART100 systems were utilized in the treatment of over 30 patients across cardiopulmonary and surgical cases, directly influencing the hospital's decision to transition from clinical assessment to commercial procurement.
- Strategic Importance: This order not only provides Inspira with a crucial hospital reference but also lays the groundwork for ongoing commercial discussions with additional U.S. and international hospital systems, demonstrating the operational value of the ART100 platform in real hospital use.
- Future Development Potential: The Director of Extracorporeal Technology at NYU Langone noted that the ART100 showcased flexibility and economic potential, indicating a promising direction for the future of extracorporeal support technologies, which could open up more market opportunities for Inspira.
See More
Inspira Technologies Reshapes Strategy with Quantum Connectivity Focus
- Strategic Restructuring: Inspira Technologies aims to become a foundational connectivity layer for the quantum computing industry through the acquisition of the AME platform, with market projections reaching $72 billion by 2035, highlighting the company's strategic importance in a rapidly growing tech sector.
- Accelerated Commercial Activity: Within weeks of the acquisition, Inspira deployed an AME system at a U.S. defense customer and generated over $1 million in revenue from recent transactions, demonstrating strong demand and market potential for its platform.
- Medical Business Optimization: The company is actively working to sell parts of its medical business to reduce costs and unlock strategic value, with expectations to finalize a transaction by Q3 2026, potentially providing significant non-dilutive capital to strengthen the balance sheet.
- Quantum Connectivity Collaboration: A joint development agreement with Qarakal Quantum Ltd. will advance the validation of Inspira's quantum connectivity architecture, expected to further enhance the company's market position within the quantum ecosystem.
See More
Inspira Secures $596,000 Order for AME System
- Significant Order Value: Inspira Technologies has secured a $596,000 purchase order from a leading Irish technological research university, with 40% of the upfront payment already received, which not only provides immediate cash flow but also lays the groundwork for future recurring revenue.
- Technology Fit: The order involves an Additively Manufactured Electronics (AME) system capable of fabricating complex three-dimensional structures with micron-level precision, directly addressing the customer's needs in information and communications technology and quantum networking research, showcasing Inspira's competitiveness in the high-tech market.
- Recurring Revenue Stream: Beyond the system price, the order establishes a recurring revenue stream from proprietary consumables, wear parts, and fixed annual service fees, enhancing the company's financial stability and long-term profitability through this structured revenue model.
- Market Expansion Potential: Inspira plans to deliver and deploy the system in the coming weeks, accompanied by tailored advanced application training for the university's research teams, with expectations that this will serve as a reference installation to foster engagement with additional academic and commercial institutions across Europe and beyond.
See More
Inspira Successfully Delivers AME System to Tier-1 U.S. Defense Customer
- Successful System Delivery: Inspira Technologies has successfully delivered its Additively Manufactured Electronics (AME) system to a Tier-1 U.S. defense customer, marking a significant enhancement in the company's commercial execution in the defense sector, which is expected to drive future financial growth.
- Strategic Partnership Opportunity: This delivery not only meets the customer's needs in advanced technologies such as quantum computing and superconducting systems but also establishes a recurring revenue stream for Inspira, ensuring long-term profitability beyond the initial system sale.
- Technological Advantage Realized: Inspira's AME platform is specifically designed to overcome hardware bottlenecks related to complex component integration and extreme miniaturization, enabling rapid fabrication of highly integrated electronic structures, thereby enhancing its application capabilities in high-density and thermally optimized operations.
- Market Demand Confirmation: CEO Dagi Ben-Noon stated that this deployment confirms the commercial demand for the AME platform in top-tier defense operations, potentially serving as a powerful catalyst for the company's accelerating financial momentum and growth.
See More
Inspira Technologies Advances in Quantum Computing with Major Client Engagement
- Technology Implementation Launch: Inspira Technologies has announced the commencement of AME technology implementation with one of the world's top ten U.S. companies, marking a significant step in its strategic expansion into advanced technology markets, which is expected to enhance the company's market share in quantum computing.
- Client Validation of Platform: The client operates at the forefront of artificial intelligence and computing infrastructure, and the application of Inspira's AME platform at their R&D facility will provide high-level validation of the technology's practical effectiveness, enhancing market confidence in the company.
- Revenue Generation Potential: This collaboration not only strengthens the ongoing commercial relationship with the client but also indicates a rising demand for next-generation hardware connectivity solutions, potentially generating a stable revenue stream for the company.
- Strategic Opportunity Expansion: Inspira believes that the client's participation will support additional strategic opportunities, further solidifying its AME platform's position in advanced technology markets and driving the company's future growth potential.
See More
